We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$69.8B
AUM Growth
+$4.21B
Cap. Flow
+$972M
Cap. Flow %
1.39%
Top 10 Hldgs %
17.51%
Holding
798
New
98
Increased
330
Reduced
232
Closed
66

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$555M
2
AIG icon
American International
AIG
+$485M
3
TSN icon
Tyson Foods
TSN
+$427M
4
MDT icon
Medtronic
MDT
+$332M
5
NXPI icon
NXP Semiconductors
NXPI
+$325M

Sector Composition

Rank Sector Weight
1 Financials 26.56%
2 Healthcare 14.6%
3 Industrials 13.24%
4 Technology 12.64%
5 Energy 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$950B
$1.75B 2.5%
26,449,258
-87,273
-0.3% -$5.68M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.41B 2.01%
10,647,367
+802,952
+8% +$108M
WFC icon
3
Wells Fargo
WFC
$263B
$1.38B 1.97%
25,346,483
-76,036
-0.3% -$4.13M
MSFT icon
4
Microsoft
MSFT
$2.92T
$1.28B 1.84%
23,094,697
+171,842
+0.7% +$9.04M
C icon
5
Citigroup
C
$222B
$1.21B 1.73%
23,353,102
+172,279
+0.7% +$9.14M
COF icon
6
Capital One
COF
$130B
$1.19B 1.7%
16,447,655
+167,066
+1% +$12.8M
JNJ icon
7
Johnson & Johnson
JNJ
$643B
$1.16B 1.66%
11,286,625
-2,323,986
-17% -$234M
OXY icon
8
Occidental Petroleum
OXY
$53.6B
$968M 1.39%
14,344,873
+92,626
+0.6% +$6.66M
ATVI
9
DELISTED
Activision Blizzard
ATVI
$952M 1.36%
24,600,073
-4,311,871
-15% -$155M
PFE icon
10
Pfizer
PFE
$144B
$937M 1.34%
30,605,789
-3,656,468
-11% -$115M
CSCO icon
11
Cisco
CSCO
$456B
$847M 1.21%
31,185,308
-3,010,922
-9% -$83.1M
RTN
12
DELISTED
Raytheon Company
RTN
$809M 1.16%
6,492,498
-504,866
-7% -$60.7M
CB icon
13
Chubb
CB
$141B
$802M 1.15%
6,863,667
+650,321
+10% +$73.6M
DFS
14
DELISTED
Discover Financial Services
DFS
$791M 1.13%
14,758,676
+2,547,030
+21% +$141M
PSX icon
15
Phillips 66
PSX
$82.5B
$781M 1.12%
9,551,238
-428,110
-4% -$36.9M
MRK icon
16
Merck
MRK
$326B
$773M 1.11%
15,333,478
-2,116,255
-12% -$107M
ESRX
17
DELISTED
Express Scripts Holding Company
ESRX
$773M 1.11%
8,841,098
+216,282
+3% +$18.5M
FITB
18
Fifth Third Bancorp
FITB
$52.4B
$731M 1.05%
36,384,562
+2,084,783
+6% +$41.3M
EOG icon
19
EOG Resources
EOG
$74.4B
$694M 0.99%
9,807,109
+1,776,409
+22% +$144M
LBTYK icon
20
Liberty Global Class C
LBTYK
$3.4B
$694M 0.99%
19,608,061
+2,209,486
+13% +$79.7M
GILD icon
21
Gilead Sciences
GILD
$167B
$692M 0.99%
6,843,182
+93,588
+1% +$9.74M
DAL icon
22
Delta Air Lines
DAL
$58.8B
$659M 0.94%
13,005,283
+889,679
+7% +$44M
LMT icon
23
Lockheed Martin
LMT
$134B
$644M 0.92%
2,966,282
+37,925
+1% +$8.23M
TFC icon
24
Truist Financial
TFC
$64.7B
$638M 0.91%
16,883,164
-142,598
-0.8% -$5.36M
VZ icon
25
Verizon
VZ
$201B
$631M 0.9%
13,662,183
+3,590,873
+36% +$163M

Similar funds

Boston Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Boston Partners held 798 positions worth $69.8B, up 6.4% from $65.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners's Q4 2015 filing shows 98 new, 330 increased, 232 reduced and 66 closed positions. Its largest new stake was Hewlett Packard: 58,352,288 shares worth $516M. The largest sale was Apple, an estimated $555M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q4 2015 buy was Hewlett Packard: 58,352,288 shares worth $516M.
  • Boston Partners added most to Flex in Q4 2015, an estimated $308M increase.
  • Boston Partners's biggest Q4 2015 reduction was Apple, cutting an estimated $555M.
  • Boston Partners fully exited Pediatrix Medical in Q4 2015, selling an estimated $63.4M.
  • Boston Partners's ten largest holdings make up 18% of its $69.8B portfolio in Q4 2015.
  • Boston Partners opened 98 new positions and closed 66 in Q4 2015.
  • Boston Partners's portfolio value rose 6.4% quarter-over-quarter to $69.8B.

Based on Boston Partners's 13F filing for Q4 2015, filed 8 Feb 2016.